Re-engineering The Clinical Research Enterprise in Response to COVID-19: The Clinical Translational Science Award (CTSA) experience and proposed playbook for future pandemics

The 2020 COVID-19 pandemic has had a profound impact on the clinical research enterprises at the 60 Clinical and Translational Science Award (CTSA) Hubs throughout the nation. There was simultaneously a need to expand research to obtain crucial data about disease prognosis and therapy and enormous l...

Descripción completa

Detalles Bibliográficos
Autores principales: Coller, Barry S., Buse, John B., Kimberly, Robert P., Powderly, William G., Zand, Martin S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Special Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137226/
https://www.ncbi.nlm.nih.gov/pubmed/34192053
http://dx.doi.org/10.1017/cts.2021.10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137226/
https://www.ncbi.nlm.nih.gov/pubmed/34192053
http://dx.doi.org/10.1017/cts.2021.10

Ejemplares similares